425 related articles for article (PubMed ID: 24996125)
21. The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales.
Sonnenberg P; Crowcroft NS; White JM; Ramsay ME
Arch Dis Child; 2007 Sep; 92(9):786-9. PubMed ID: 17412744
[TBL] [Abstract][Full Text] [Related]
22. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile.
Bechini A; Boccalini S; Tiscione E; Pesavento G; Mannelli F; Peruzzi M; Rapi S; Mercurio S; Bonanni P
Eur J Public Health; 2012 Feb; 22(1):133-9. PubMed ID: 20880991
[TBL] [Abstract][Full Text] [Related]
23. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
[TBL] [Abstract][Full Text] [Related]
24. MMR vaccine uptake rates: a data validation study.
Ghebrehewet S; Falconer M; McDonald P; Schlecht B
Commun Dis Public Health; 2003 Jun; 6(2):144-6. PubMed ID: 12889295
[TBL] [Abstract][Full Text] [Related]
25. Progress toward measles and rubella elimination in Egypt.
El Sayed N; Kandeel N; Barakat I; Moussa I; Alexander JP; Naouri B; Reef SE
J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180
[TBL] [Abstract][Full Text] [Related]
26. Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine.
Mixer RE; Jamrozik K; Newsom D
J Epidemiol Community Health; 2007 Sep; 61(9):797-801. PubMed ID: 17699534
[TBL] [Abstract][Full Text] [Related]
27. MMR vaccination and disease elimination: the Finnish experience.
Davidkin I; Kontio M; Paunio M; Peltola H
Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
[TBL] [Abstract][Full Text] [Related]
28. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
[TBL] [Abstract][Full Text] [Related]
29. [35-year measles, mumps, rubella vaccination assessment in France].
Reinert P; Soubeyrand B; Gauchoux R
Arch Pediatr; 2003 Nov; 10(11):948-54. PubMed ID: 14613687
[TBL] [Abstract][Full Text] [Related]
30. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
31. Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys.
Ramsay ME; Yarwood J; Lewis D; Campbell H; White JM
Br J Gen Pract; 2002 Nov; 52(484):912-6. PubMed ID: 12434960
[TBL] [Abstract][Full Text] [Related]
32. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland.
Paunio M; Virtanen M; Peltola H; Cantell K; Paunio P; Valle M; Karanko V; Heinonen OP
Am J Epidemiol; 1991 Jun; 133(11):1152-60. PubMed ID: 2035518
[TBL] [Abstract][Full Text] [Related]
33. The measles/rubella immunisation campaign in Scotland.
Skinner R; Christie P; Cowden JM
Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
35. [Measles, mumps, rubella and varicella: antibody titration and vaccinations in a large hospital].
Cologni L; Belotti L; Bacis M; Moioli F; Goglio A; Mosconi G
G Ital Med Lav Ergon; 2012; 34(3 Suppl):272-4. PubMed ID: 23405639
[TBL] [Abstract][Full Text] [Related]
36. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft.
Matter HC; Cloetta J; Zimmermann H
J Epidemiol Community Health; 1995 Aug; 49 Suppl 1(Suppl 1):4-8. PubMed ID: 7561669
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
Yadav S; Thukral R; Chakarvarti A
Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
[TBL] [Abstract][Full Text] [Related]
38. Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument.
Brown KF; Shanley R; Cowley NA; van Wijgerden J; Toff P; Falconer M; Ramsay M; Hudson MJ; Green J; Vincent CA; Kroll JS; Fraser G; Sevdalis N
Vaccine; 2011 Feb; 29(8):1700-9. PubMed ID: 21185850
[TBL] [Abstract][Full Text] [Related]
39. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
Pareek M; Pattison HM
Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
[TBL] [Abstract][Full Text] [Related]
40. When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa?
Cameron NA
Vaccine; 2012 Sep; 30 Suppl 3():C58-60. PubMed ID: 22939023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
